HealthQuill Parkinson's disease
Supernus Pharmaceuticals Inc’s injection for treating people with advanced Parkinson’s disease got a green light from the US regulator after two earlier rejections.
Drugs Health Medical

Supernus’ injection to treat advanced Parkinson’s gets US regulator’s nod

Supernus Pharmaceuticals Inc’s injection for treating people with advanced Parkinson’s disease got a green light from the US regulator after two earlier rejections.

Read More
Researchers at Cambridge are developing implants that could help repair damaged brain cells and treat diseases like Parkinson’s.
Drugs Health Research

Cambridge researchers making brain implants to treat Parkinson’s

Researchers at Cambridge are developing implants that could help repair damaged brain cells and treat diseases like Parkinson’s.

Read More
Dancing has a positive effect on the “mood circuits” in the brain and can lower depression in people with Parkinson’s disease, according to an observational study on 23 patients conducted by Canada’s York University.
Drugs Health Medical

Dancing can help lower depression in people with Parkinson’s disease

Dancing has a positive effect on the “mood circuits” in the brain and can lower depression in people with Parkinson’s disease, according to.

Read More
Moderna Inc., a biotechnology company, and Merck announced that an experimental personalised cancer vaccine, based on the messenger RNA (mRNA) technology, has received Breakthrough Therapy Designation from the USFDA.
Health Research

Research identifies RNA structures linked to Parkinson’s

HQ Team November 20, 2024: A team of researchers from Kumamoto University has found that unique RNA structures known as G-quadruplexes (G4s) facilitate.

Read More
Drugs Medical Pharma

FDA approves AbbVie’s new drug for advanced Parkinson’s disease

HQ Team October 19, 2024: The U.S. Food and Drug Administration (FDA) has approved AbbVei’s drug Vyalev for the treatment of advanced Parkinson’s.

Read More
People with a history of damage to the lining of their upper gastrointestinal (GI) tract are at a 76% higher risk of developing Parkinson’s disease, a Beth Israel Deaconess Medical Center study finds.
Drugs Health Pharma

GI tract damage may increase the risk of Parkinson’s disease by 76% 

People with a history of damage to the lining of their upper gastrointestinal (GI) tract are at a 76% higher risk of developing.

Read More
Smoking cigarettes may protect humans from neurodegeneration and prevent the accumulation of a key Parkinson’s-associated protein in the brain, new research on mice reveals.
Drugs Health Pharma

Cigarette smoking may help fight Parkinson’s disease: Harvard research

Smoking cigarettes may protect humans from neurodegeneration and prevent the accumulation of a key Parkinson’s-associated protein in the brain, new research on mice.

Read More
An oral investigational drug jointly developed by Biogen Inc., and Sage Therapeutics Inc., failed to stop essential tremors in patients, forcing the companies to halt the trial.
Drugs Health Pharma

Biogen, Sage halt tremor trial after ‘disappointing’ oral drug results

An oral investigational drug jointly developed by Biogen Inc., and Sage Therapeutics Inc., failed to stop essential tremors in patients, forcing the companies.

Read More
Scotland's researchers and doctors have performed a non-invasive operation on a patient with Parkinson’s disease using the country’s first ultrasound thalamotomy that allowed him to regain control of his finger movements.
Drugs Health Pharma

Scotland’s medical university team cures Parkinson’s patient’s tremors

Scotland's researchers and doctors have performed a non-invasive operation on a patient with Parkinson’s disease using the country’s first ultrasound thalamotomy that allowed.

Read More
Understanding the genetic and environmental factors contributing to the development of Parkinson’s is crucial for improving prevention and treatment strategies. 
Climate Health Opinion Pharma

Opinion: Pesticide exposure and its link to Parkinson’s disease 

Understanding the genetic and environmental factors contributing to the development of Parkinson’s is crucial for improving prevention and treatment strategies. 

Read More